Literature DB >> 11841495

Molecular analysis of HLA-DRB1 polymorphism in north-east Spain.

S Vidal1, M P Morante, E Moga, A M Mosquera, S Querol, J Garcia, J l Rodriguez-Sanchez.   

Abstract

The DRB1* polymorphism in 941 randomly selected individuals from the Umbilical Cord Blood Bank of Barcelona (92.75% of Spanish origin) was determined by sequence-based typing. The HLA profile was similar to that of other Mediterranean populations, with DRB1*0701 and *0301 being the most frequent alleles. This may be a consequence of the mixture of alleles as a result of migration from contiguous geographical areas.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11841495     DOI： 10.1046/j.0960-7420.2001.00293.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN： 0960-7420


  4 in total

1.  Human leukocyte antigen-A, -B, -C, -DRB1 allele and haplotype frequencies in Americans originating from southern Europe: contrasting patterns of population differentiation between Italian and Spanish Americans.

Authors:  Steven J Mack; Bin Tu; Ruyan Yang; Carly Masaberg; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Hum Immunol       Date:  2010-10-23       Impact factor: 2.850

2.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.

Authors:  Owen D Solberg; Steven J Mack; Alex K Lancaster; Richard M Single; Yingssu Tsai; Alicia Sanchez-Mazas; Glenys Thomson
Journal:  Hum Immunol       Date:  2008-06-09       Impact factor: 2.850

3.  HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population.

Authors:  S J Mack; B Tu; A Lazaro; R Yang; A K Lancaster; K Cao; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2008-10-24

4.  HLA-DRB1 alleles are associated with the susceptibility to sporadic Parkinson's disease in Chinese Han population.

Authors:  Congcong Sun; Lei Wei; Feifei Luo; Yi Li; Jiaobiao Li; Feiqi Zhu; Ping Kang; Rensi Xu; Lulu Xiao; Zhuolin Liu; Pingyi Xu
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.